Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001415889-24-024932

Options or other derivatives

  • Chief Financial Officer acquired 87,592 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Degnan Chris · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-10-08 Grant or award : show line 1 in the form Restricted Stock Units +13,450 13,450 D
2024-10-08 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +74,142 74,142 D
Loading xslF345X05/form4-10092024_081051.xml…